Literature DB >> 10823879

Application of the intracellular gamma interferon assay to recalculate the potency of CD8(+) T-cell responses to herpes simplex virus.

U Kumaraguru1, B T Rouse.   

Abstract

Enumeration and characterization of herpes simplex virus (HSV)-specific CD8(+) T lymphocytes are tedious and indirect. We quantitated antigen-specific CD8(+) T cells during acute and secondary stages of HSV infection using intracellular gamma interferon production upon stimulation with virus or immunodominant peptide. Results show a substantial increase in the number of CD8(+) T cells which was otherwise underestimated with the conventional limiting dilution analysis.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10823879      PMCID： PMC112059          DOI： 10.1128/jvi.74.12.5709-5711.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  9 in total

1.  Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Authors:  M A Alexander-Miller; G R Leggatt; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

2.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

3.  The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.

Authors:  M E Wallace; R Keating; W R Heath; F R Carbone
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

5.  Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.

Authors:  M F Callan; N Steven; P Krausa; J D Wilson; P A Moss; G M Gillespie; J I Bell; A B Rickinson; A J McMichael
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Massive expansion of antigen-specific CD8+ T cells during an acute virus infection.

Authors:  E A Butz; M J Bevan
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

7.  Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis.

Authors:  B T Rouse; H S Larsen; H Wagner
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

Authors:  J E Blaney; E Nobusawa; M A Brehm; R H Bonneau; L M Mylin; T M Fu; Y Kawaoka; S S Tevethia
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific.

Authors:  J D Wilson; G S Ogg; R L Allen; P J Goulder; A Kelleher; A K Sewell; C A O'Callaghan; S L Rowland-Jones; M F Callan; A J McMichael
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307
  9 in total
  9 in total

1.  Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.

Authors:  Teng Chih Yang; Kelley Dayball; Yong Hong Wan; Jonathan Bramson
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.

Authors:  Felix N Toka; Malgorzata Gierynska; Barry T Rouse
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1.

Authors:  Felix N Toka; Susmit Suvas; Barry T Rouse
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection.

Authors:  Shalini Sharma; Naveen K Rajasagi; Tamara Veiga-Parga; Barry T Rouse
Journal:  Microbes Infect       Date:  2014-06-21       Impact factor: 2.700

5.  T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.

Authors:  Shalini Sharma; Aarthi Sundararajan; Amol Suryawanshi; Naveen Kumar; Tamara Veiga-Parga; Vijay K Kuchroo; Paul G Thomas; Mark Y Sangster; Barry T Rouse
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-03       Impact factor: 11.205

6.  Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection.

Authors:  Udayasankar Kumaraguru; Malgorzata Gierynska; Shanna Norman; Barry D Bruce; Barry T Rouse
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.

Authors:  Shalini Sharma; Sachin Mulik; Naveen Kumar; Amol Suryawanshi; Barry T Rouse
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

8.  Antigenic peptides complexed to phylogenically diverse Hsp70s induce differential immune responses.

Authors:  Udayasankar Kumaraguru; C A Gouffon; R A Ivey; Barry T Rouse; Barry D Bruce
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

9.  CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.

Authors:  Susmit Suvas; Uday Kumaraguru; Christopher D Pack; Sujin Lee; Barry T Rouse
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.